Article
Microglia replacement halts the progression of microgliopathy in mice and humans.
Science (New York, N.Y.) - 10 Jul 2025
Wu Jingying, Wang Yafei, Li Xiaoyu, Ouyang Pei, Cai Yuanyuan, He Yang, Zhang Mengyuan, Luan Xinghua, Jin Yuxiao, Wang Jie, Xiao Yujie, Liang Yuqing, Xie Fang, Shu Yousheng, Hu Jiong, Chang Chunkang, Jiang Jieling, Wu Dong, Zhao Youshan, Liu Taohui, Li Yuxin, Huang Xiaojun, Li Yao, Zhang Junfang, Cao Yuwen, Cheng Xin, Mao Ying, Rao Yanxia, Cao Li, Peng Bo
Abstract excerpt
Colony-stimulating factor 1 receptor (CSF1R) is primarily expressed in microglia. Its monoallelic mutation causes CSF1R-associated microgliopathy (CAMP), a major form of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and a fatal neurological disease without clinical cure. We developed mouse models harboring human hotspot mutations of CAMP and replaced CSF1R-deficient microglia...
Read the complete abstract on PubMedTopics
- Microglia
- Animals
- Humans
- Mice
- Disease Progression
